Abstract

In the field of drug research and development, the investigation of drug-drug interactions (DDIs) is a vital research area. Many clinical tools are used in the industry providing the broad lists of DDIs. But these tools can return unpredictable results, only limited to specific types of interaction. Also these tools lack the synchronized database of drug-drug interaction. In our research work, we are proposing a novel pattern recognition based technique that investigates the patterns of natural language processing for extraction of drug-drug interaction. The proposed technique is novel in the sense that is uses a smaller feature set, computationally less expensive, yet yielding better results as compared to previous techniques. The proposed technique is based on Bioinformatics and NLP (Natural Language processing). For this research paper, we have collected biomedical data such as drug names, drug identification numbers (ID’s) and different types of drug-drug interaction sentences from DrugBank(a free online resource). Through parsing the sentences, we investigated the patterns for drugdrug interaction extraction. For performance evaluation of our proposed work, we applied three different types of classification models i.e. Naïve Bayes, J48 (decision tree) and Random Forest. The results achieved by our technique are: F-score 82.4%, Precision 81.6% and Recall 83.2%. The best accuracy achieved is with Random Forest, which is 99.0%. Comparison with previous research shows that our proposed technique provides better results. Keywords: Bioinformatics, biomedical, classification, drug, drug bank, drug-drug interaction, pattern recognition, NLP.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.